|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 64.06 EUR | -0.37% |
|
+0.72% | +16.68% |
| Fiscal Period: December | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
Revenues | 54.3B | 57.79B | 59.38B | 59.77B | 59.32B | |||||
Total Revenues | 54.3B | 57.79B | 59.38B | 59.77B | 59.32B | |||||
Cost of Goods Sold, Total | 23.1B | 26.3B | 27.4B | 26.74B | 26.14B | |||||
Gross Profit | 31.21B | 31.48B | 31.98B | 33.02B | 33.18B | |||||
Selling General & Admin Expenses, Total | 17.65B | 17.63B | 18.26B | 18.43B | 18.21B | |||||
Other Operating Expenses | -514M | -558M | -661M | -651M | -713M | |||||
Other Operating Expenses, Total | 17.13B | 17.07B | 17.6B | 17.78B | 17.49B | |||||
Operating Income | 14.07B | 14.41B | 14.38B | 15.25B | 15.68B | |||||
Interest Expense, Total | -3.85B | -3.81B | -3.91B | -3.63B | -3.34B | |||||
Interest And Investment Income | 113M | 294M | 565M | 591M | 511M | |||||
Net Interest Expenses | -3.74B | -3.51B | -3.34B | -3.04B | -2.83B | |||||
Income (Loss) On Equity Invest. | 248M | 299M | 295M | 329M | 378M | |||||
Currency Exchange Gains (Loss) | -101M | -363M | -353M | -147M | -386M | |||||
Other Non Operating Income (Expenses) | -1.16B | -1.15B | -1.43B | -1.14B | -1.11B | |||||
EBT, Excl. Unusual Items | 9.32B | 9.68B | 9.55B | 11.24B | 11.74B | |||||
Restructuring Charges | -172M | -110M | -142M | -156M | -116M | |||||
Merger & Related Restructuring Charges | -42M | 273M | - | - | -5M | |||||
Impairment of Goodwill | - | - | -20M | - | - | |||||
Gain (Loss) On Sale Of Assets | -182M | 187M | 73M | 88M | 95M | |||||
Asset Writedown | - | -176M | -212M | -9M | -15M | |||||
Legal Settlements | 344M | 369M | 212M | 191M | 117M | |||||
Other Unusual Items | -806M | -702M | -337M | -788M | -489M | |||||
EBT, Incl. Unusual Items | 8.46B | 9.52B | 9.12B | 10.57B | 11.33B | |||||
Income Tax Expense | 2.35B | 1.93B | 2.23B | 3.15B | 2.85B | |||||
Earnings From Continuing Operations | 6.11B | 7.6B | 6.89B | 7.42B | 8.48B | |||||
Earnings Of Discontinued Operations | - | - | - | - | - | |||||
Net Income to Company | 6.11B | 7.6B | 6.89B | 7.42B | 8.48B | |||||
Minority Interest | -1.44B | -1.63B | -1.55B | -1.56B | -1.64B | |||||
Net Income - (IS) | 4.67B | 5.97B | 5.34B | 5.86B | 6.84B | |||||
Net Income to Common Incl Extra Items | 4.67B | 5.97B | 5.34B | 5.86B | 6.84B | |||||
Net Income to Common Excl. Extra Items | 4.67B | 5.97B | 5.34B | 5.86B | 6.84B | |||||
Per Share Items | ||||||||||
Net EPS - Basic | 2.33 | 2.97 | 2.65 | 2.92 | 3.45 | |||||
Basic EPS - Continuing Operations | 2.33 | 2.97 | 2.65 | 2.92 | 3.45 | |||||
Basic Weighted Average Shares Outstanding | 2.01B | 2.01B | 2.02B | 2B | 1.98B | |||||
Net EPS - Diluted | 2.28 | 2.91 | 2.6 | 2.86 | 3.39 | |||||
Diluted EPS - Continuing Operations | 2.28 | 2.91 | 2.6 | 2.86 | 3.39 | |||||
Diluted Weighted Average Shares Outstanding | 2.04B | 2.05B | 2.05B | 2.04B | 2.02B | |||||
Normalized Basic EPS | 2.18 | 2.2 | 2.19 | 2.73 | 2.87 | |||||
Normalized Diluted EPS | 2.14 | 2.16 | 2.15 | 2.67 | 2.82 | |||||
Dividend Per Share | 0.57 | 0.8 | 0.91 | 1.04 | 1.35 | |||||
Payout Ratio | 50.62 | 40.91 | 56.41 | 45.64 | 66.45 | |||||
American Depositary Receipts Ratio (ADR) | 0.17 | 0.17 | 0.17 | 0.17 | 0.17 | |||||
Supplemental Items | ||||||||||
EBITDA | 17.82B | 18.2B | 18.21B | 19.11B | 19.42B | |||||
EBITA | 14.34B | 14.58B | 14.55B | 15.46B | 15.96B | |||||
EBIT | 14.07B | 14.41B | 14.38B | 15.25B | 15.68B | |||||
EBITDAR | - | - | - | - | - | |||||
Effective Tax Rate - (Ratio) | 27.76 | 20.24 | 24.48 | 29.83 | 25.16 | |||||
Total Current Taxes | 2.7B | 2.63B | 2.92B | 3.46B | 3.27B | |||||
Total Deferred Taxes | -348M | -701M | -689M | -311M | -420M | |||||
Normalized Net Income | 4.38B | 4.42B | 4.42B | 5.47B | 5.7B | |||||
Interest Capitalized | 10M | - | - | - | - | |||||
Interest on Long-Term Debt | 200M | 194M | 218M | 206M | 144M | |||||
Non-Cash Pension Expense | 96M | 88M | 100M | 100M | 93M | |||||
Supplemental Operating Expense Items | ||||||||||
Selling and Marketing Expenses | 13.18B | 13.14B | 13.44B | 13.36B | 13.47B | |||||
General and Administrative Expenses | 4.39B | 4.41B | 4.74B | 4.98B | 4.67B | |||||
Research And Development Expense From Footnotes | 298M | 268M | 256M | 222M | 194M | |||||
Net Rental Expense, Total | - | - | - | - | - | |||||
Imputed Operating Lease Interest Expense | - | - | - | - | - | |||||
Imputed Operating Lease Depreciation | - | - | - | - | - | |||||
Stock-Based Comp., Other (Total) | 510M | 448M | 570M | 644M | 625M | |||||
Total Stock-Based Compensation | 510M | 448M | 570M | 644M | 625M |
- Stock Market
- Equities
- ABI Stock
- Financials Anheuser-Busch InBev SA/NV
- Income Statement
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition















